Cefadroxil Capsule / 500 mg / 50 Count
Cefadroxil Capsule
500 mg / 50 CountBack to Products
Brand name: Duricef®
Cefadroxil is indicated for the treatment of patients with infection caused by susceptible strains of the designated organisms in the following diseases:
Urinary tract infections caused by E. coli, P. mirabilis, and Klebsiella species.
Skin and skin structure infections caused by staphylococci and/or streptococci.
Pharyngitis and/or tonsillitis caused by Streptococcus pyogenes (Group A beta-hemolytic streptococci).
For more information please see the prescribing information on DailyMed.
Product Information | |
---|---|
Product Name | Cefadroxil Capsule |
Strength | 500 mg |
Strength | 500 mg |
Dosage Form | Capsule |
Pack Size | 50 Count |
NDC | 57237-096-50 |
OTC/Rx | Rx |
TE Code | AB |
Product Characteristics | |
---|---|
Color | Maroon/white colored |
Shape | Capsule |
Gluten | Free from Gluten |
Lactose | Free from Lactose |
Sweeteners | Not Applicable |
Soy | Free from Soy |
Gelatin | Contains Gelatin |
Allergen Info | Free from dairy products and egg products |
Other Product Info | Not Applicable |
Other Information | |
---|---|
Inactive Ingredients | Lactose monohydrate, magnesium stearate, FD&C Blue no. 1, D&C Red no. 28, FD&C Red no. 40, titanium dioxide, gelatin, sodium lauryl sulfate, ferrosoferric oxide |
Imprint/Markings | C;97 |
Special Instructions | Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. |
Product Shelf Life | 24 months |
*The brand names listed are not owned by Rising Pharma. Rising Pharma products are generic equivalents to the respective brand names listed on this website.